
STARTS NOW! Rebel's Edge 1pm 🕐 $VNDA $ACLX $NVO $DPZ 🏈 NAJARIAN SPORTS 🏴☠️ with @petenajarian Winter Olympics: Hockey Finals was scripted perfectly, but did it reach 1980 levels? NFL: Chicago Bears, will they need to change the team's name? Indiana looking to build a Dome, NW https://t.co/CUnDFsQQz7
4 stocks to watch on Monday: LLY, NVO, APO, TTE
171.31BUSD

See which Billionaires own this investment
Type
Common Stock
Exchange
NYSE
Currency Code
USD
Currency Name
US Dollar
Country Name
USA
Country ISO
US
ISIN
US6701002056
CUSIP
670100205
Sector
Healthcare
Industry
Drug Manufacturers - General
Fiscal Year End
December
IPO date
-
Updated At
-
PE Ratio
9.55
PEG Ratio
4.06
Book Value
7.42
Dividend Share
11.7
Dividend Yield
4.75%
Earnings Share
3.96
Wall Street Target Price
45.69
EPS Estimate Current Year
23.67
EPS Estimate Next Year
23.37
EPS Estimate Current Quarter
4.6207
EPS Estimate Next Quarter
4.308
Most Recent Quarter
-
Revenue TTM
333,650,001,920
Gross Profit TTM
278,039,003,136
EBITDA
181,555,003,392
Profit Margin
33.92%
Return On Assets TTM
19.05%
Return On Equity TTM
58.38%
Revenue Per Share TTM
75.248
Qtly Revenue Growth YOY
5.60%
Diluted Eps TTM
3.96
Qtly Earnings Growth YOY
-15.80%
Trailing PE
9.55
Forward PE
11
Price Sales TTM
0.4996
Price Book MRQ
5.3484
Enterprise Value Revenue
3
Enterprise Value EBITDA
7
270.72
1.26%286.40
1.04%133.75
0.66%152.00
-2.88%471.42
-1.79%470.55
-1.60%58.46
-0.92%173.83
-0.87%150.00
-0.82%1346.12
-0.47%